SANTIAGO, Chile, Nov. 15, 2013 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE:CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialities and prescription medicines, today issued a firm intention announcement (“FIA”) to acquire 100% of the issued share capital (excluding the Bophelo Scheme Shares and the Treasury Shares) of Adcock Ingram Holdings Limited (“Adcock Ingram”), the South Africa pharmaceutical company, for a total consideration of approximately US$1.26 billion (“Acquisition”). Terms not defined herein have the meaning attributed to them in the FIA.
Help employers find you! Check out all the jobs and post your resume.
